 |
 |
 |
 |
 |
 |
 |
Selected Releases |
||
 |
NxThera Completes $21.6 Million Series B Financing ST. PAUL, MN | NxThera, a medical device company developing its innovative and proprietary Rezum vapor ablation system to treat a variety of endourology conditions, beginning with benign prostatic hyperplasia (BPH), today announced the recent completion of a $21.6 million round of Series B equity financing. 10 04 11 Release > |
|
 |
Luminex Acquires EraGen to Expand Molecular Diagnostic and Infectious Disease Capabilities AUSTIN, TX and MADISON, WI | Luminex Corporation (NASDAQ: LMNX) announced a definitive agreement to acquire privately-held EraGen Biosciences, an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications. 06 21 11 Release > |
|
 |
Veran Completes Financing Worth Over $15 Million ST. LOUIS | Veran Medical Technologies announced that it has recently completed a financing worth over $15 million. Participants in the recent financing included existing investors and a new strategic partner. The proceeds will be used to commercialize products on the IG4 four-dimensional image guidance platform of technology. 03 17 11 Release > |
|
 |
Veniti Secures $13.5 Million in Series A Financing ST. LOUIS | Veniti, a medical device company, announced that it has raised $13.5 million in Series A financing. The proceeds will be used to acquire two additional medical device companies and begin commercialization of multiple products singularly focused on treating chronic venous disease. 03 08 11 Release > |
|
 |
AirXpanders Raises $8 Million Through Series C Financing, Working Capital Line PALO ALTO, CA | AirXpanders, a company developing technology to address current unmet needs for patients who require tissue expansion for reconstructive surgery, announced that it raised $8 million through two financings. The proceeds will support an IDE trial and an international launch of the first-ever patient-controlled tissue expansion system for mastectomy patients. 03 02 11 Release > |
|
 |
Monsanto Acquires Agricultural Technology Leader Divergence ST. LOUIS | Monsanto Company (NYSE: MON) announced that it has acquired Divergence, a privately-held St. Louis-based biotechnology research and development company. Divergence’s current focus is its work with parasitic nematodes, including developing biotechnology traits for nematode control and nematicides with novel modes of action and superior safety profiles. 02 22 11 Release > |
|
|
GE Healthcare Named Exclusive U.S. Distributor of Veran IG4 Navigation System WAUKESHA, WI and ST. LOUIS | GE Healthcare and Veran Medical Technologies today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive U.S. distributor and reseller of Veran's IG4 navigation system. The deal brings together GE Healthcare's best-in-class Innova imaging systems and Veran's innovative electromagnetic navigation to create a comprehensive interventional oncology solution under a single point of contact. 01 18 11 Release > |
|
 |
Singulex Receives U.S. Patents for Single Molecule Detection of Protein Biomarkers and Key Biomarker for Cardiac Risk Monitoring ALAMEDA, CA | Singulex today announced that the U.S. Patent & Trademark Office has issued two patents related to the company's Erenna technology, for the quantitative measurement of single molecules in complex biological samples. The patented technology enables the Erenna Immunoassay System to integrate single-molecule counting into microparticle-based immunoassays that dramatically improve assay sensitivity. 12 14 10 Release > |
|
 |
International Technidyne Corporation (ITC) Acquired by Warburg Pincus SAN DIEGO, CA and EDISON, NJ | International Technidyne Corporation (ITC) today announced the completion of its sale to Warburg Pincus, the global private equity firm, in an all-cash transaction valued at $55 million. Immediately thereafter, ITC merged with Nexus Dx to create a global provider of point-of-care testing systems and advanced diagnostic solutions to be run by Nexus Dx CEO Jim Merselis. 11 04 10 Release > |
|
 |
BioMarin Pharmaceutical Agrees to Pay Up to $115 Million for ZyStor NOVATO, CA | BioMarin Pharmaceutical (NASDAQ: BMRN) today announced that it has acquired ZyStor Therapeutics, a privately held company developing enzyme replacement therapies for the treatment of lysomal storage disorders utilizing glycosylation-independent lysosomal targeting. ZyStor’s lead product candidate, ZC-701, treats Pompe disease. 08 17 10 Release > |
|
 |
EndoStim Raises $6 Million in Series B Funding ST. LOUIS | EndoStim, a medical device company, today announced that it has raised $6 million in Series B equity financing. EndoStim will use the new funds to continue clinical trials and pursue CE Mark and FDA approval of its lower-cost, minimally-invasive therapy for treating Gastroesophageal Reflux Disease (GERD). 07 19 10 Release > |
|
|
EraGen Announces FDA Clearance of First Herpes Simplex Virus PCR Test MADISON, WI | EraGen Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for EraGen’s MultiCode-RTx HSV 1&2 Kit. It is a polymerase chain reaction (PCR)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (HSV 1&2) DNA in vaginal lesions of symptomatic female patients. 05 19 10 Release > |
|
|
Veran Installs First SPiN Drive at Duke University Medical Center ST. LOUIS | Veran today announced that it has recently completed its first installation and performed several procedures at Duke with its FDA-clearedSPiN Drive system.SPiN enables clinicians to access, biopsy, and treat potentially cancerous Solitary Pulmonary Nodules (SPN’s). 04 22 10 Release > |
|
|
New Funding Validates Importance of Divergence’s Work on Nematodes ST. LOUIS | Divergence today announced that it has received $500,000 in Small Business Innovation Research (SBIR) grants, as well as renewed funding from the National Corn Growers Association (NCGA), to support the company’s innovative work to prevent crop damage from nematodes. 02 09 10 Release > |
|
 |
Akermin Raises $10 Million in Series B Financing Round ST. LOUIS | Akermin today announced that it has closed a $10 million Series B financing round. Akermin will use the new funds to develop and bring to market its transformational carbon capture system for large industrial applications such as power plant flue gas. 01 26 10 Release > |
|
 |
Attune Foods Announces Acquisition of Uncle Sam and Erewhon Cereal Brands from US Mills SAN FRANCISCO | Attune Foods, maker of the world’s first probiotic chocolate bar, today announced that it has acquired two cereal brands to further expand its portfolio of great-tasting food products that deliver digestive health benefits. 12 14 09 Release > |
|
|
GE Healthcare and Veran Announce Imaging and Navigation Collaboration for Interventional Procedures CHICAGO and ST. LOUIS | GE Healthcare and Veran Medical Technologies today announced that they have collaborated to validate the compatibility of the Veran IG4 Navigation System and GE Innova® imaging systems for use in imaging suites during interventional procedures. 12 01 09 Release > |
|
|
EraGen Announces a Strategic Partnership, Licensing Agreement with Illumina MADISON, WI | EraGen Biosciences and Illumina today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements, as a first step toward advancing healthcare through leading-edge molecular tools. 11 18 09 Release > |
|
|
ZyStor Therapeutics Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease MILWAUKEE | ZyStor Therapeutics today announced that it has received clearance from the U.S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme-replacement therapy for the treatment of Pompe disease. 10 14 09 Release > |
|
 |
Travanti Pharma Acquired by Teikoku SAN JOSE and MINNEAPOLIS | Teikoku Pharma USA has acquired Minneapolis-area based Travanti Pharma, a privately held corporation that designs, develops, and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness, and ease of administration of medications delivered to the body. 05 08 09 Release > |
|
|
